About Richard Brand
Richard Brand is a chief financial officer at Maxona Pharmaceuticals.
Experience
This experience comes from Richard Brand's profile and from SEC filings. For roles taken from filings, the years are when the filings name Richard Brand in the role, so the role may have started earlier or lasted longer.
Maxona Pharmaceuticals, Inc. Current
Chief Financial Officer
investor, Consultant (2024 – Present)
2024 – Present · Malvern, PA
Develops oral pain medicines for people with acute and chronic pain.
AI
Arion Diagnostics, Inc.
Consultant
2023 – 2025
CC
CY Molecular Diagnostics (CYMD)
Sole Independent Director, Board of Directors
2022 – 2025
AC
AllFor LLC, my consulting company
Chief Financial Officer and Advisor
2024
FC
Fortune Rise Acquisition Corporation
Principal Executive Officer and Chief Financial Officer
2023
CI
CIRCULOGENE
Chief Financial Officer
2021 – 2023
MC
my consulting company
CFO, COO and Chief Commercial Officer consultant to health care
2020 – 2021
LI
Laboratory for Advanced Medicine Inc.
Consultant
2018 – 2019
GI
Geneius Biotechnology, Inc.
Board Advisor
2018
BI
BeyondSpring Inc.
CFO
2016 – 2018
KI
KenCast, Inc.
Acting CFO
2015 – 2016
MB
my own consulting business
CFO to private companies and Board Member to one
2014 – 2016
WF
Whalehaven Group of Funds
Analyst
2011 – 2015
AL
Andrews Securities, LLC
VP
2010 – 2011
GG
Gerson Lehrman Group
Council Member
2009 – 2011
GL
Global Capital Service Group, Ltd.
Advisory Council Member
2009 – 2010
YL
Yorkville Advisors LLC
Sector Head; Investment Committee; Managing Director
2007 – 2009
PM
Prospect Capital Management
External CFO; Head of Origination; Sector Head; Managing Director
2004 – 2007
CN
Caisse des Depots (Paris & NY)
Private Capital Markets Group Head
2002 – 2004
RS
Robertson Stephens
Private Capital Markets Head; Commitment Committee; Investment Fund Manager; Managing Director
1998 – 2002
Key Colleagues at Startups
The people Richard Brand works with at each company, as listed on that company's latest Form D.
Maxona Pharmaceuticals, Inc. · Form D/A, Aug 14, 2026
BS
Behshad Sheldon
Director
SF
Shahin Fatholahi
Chief Executive Officer and director
DN
David Nakamura
Director